Dennis Hallahan

Professor of Radiation Oncology, Head of the Department of Radiation Oncology, Professor of Biomedical Engineering, Professor of Cell Biology and Physiology, Professor of Pathology and Immunology, Professor of Molecular Microbiology, Elizabeth H and James S McDonnell III Distinguished Professor of Medicine

    Willing to Mentor

    Available to Mentor:

    PhD/MSTP Students

    • 14791
      Citations
    1986 …2023

    Research activity per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    Dennis Hallahan, MD has 20+ years of uninterrupted NCI/NIH funding. The Hallahan laboratory has discovered several molecular targets for drug development in cancer. Discovery strategies have included Proteomics and lipidomics. These discoveries have gone on to preclinical and clinical drug development of a number of novel cancer drugs. Most notable are inhibitors of PLA2 and the LPA receptor. More recently, the Hallahan laboratory has identified TIP1 and GRP78 as molecular targets to enhance the efficacy of radiation therapy. Dr. Hallahan’s lab has developed monoclonal antibodies and scFv antibodies to radiation inducible neoantigens that are specific to cancer. These antibodies activate immune effector cells. They have also been conjugated to therapeutic agents such as radiopharmaceuticals. More importantly, antibodies to radiation inducible TIP1 and GRP78 show efficacy in mouse models of human cancer. The Hallahan laboratory has developed several drug delivery systems using nanoparticles and liposomes. These particles have been conjugated to peptide ligands that bind to radiation inducible receptors in cancer. This approach has increased the bioavailability of doxorubicin and paclitaxel specifically to cancer. Pre-clinical efficacy and proof of concept studies have been completed. Current research combines our lead cancer specific ligand conjugated to PEG in liposomal formulation.

    Clinical interests

    Brain tumors, cancer of the central nervous system, cancer antibody development, immunotherapy, cancer drug development, radiation protecting drugs, nanoparticles, cancer drug delivery gene therapy for cancer

    Available to Mentor:

    • PhD/MSTP Students

    Fingerprint

    Dive into the research topics where Dennis Hallahan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or